Animal Vaccines Market Scope
Vaccination protects the welfare of animals by preventing or reducing disease, which in turn reduces the pain and suffering often associated with illness. Animals, like people, are susceptible to a wide range of diseases caused by viruses, bacteria, fungi, and parasites. Vaccines are available for many of these diseases, making them preventable or mitigating the losses or long-term consequences of the disease. This is particularly important for those diseases which have complex, limited treatment options available. Therefore, animal vaccines prevent diseases and minimize the clinical signs of disease in the first instance to protect the health & welfare of the animals.
According to AMA, the Global Animal Vaccines market is expected to see growth rate of 5.9%Major players have adopted various strategies such as product portfolio expansion, mergers and acquisitions, geographic expansion, agreements, and collaborations to increase their market share and strengthen their foothold in the industry. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Animal Vaccines market throughout the predicted period.
Merck & Co., Inc. (United States), Zoetis Inc. (United States), Ceva Santé Animale (France), Sanofi S.A. (France), Romvac (Romania), Vaxxinova International BV (Netherlands), The Biovac Institute (South Africa), Merial (France) and Anicon Labor GmbH (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Nexvet (Ireland), PHL Associates, Inc. (United States), Hygieia Biological Laboratories (United States), Colorado Serum Company (United States), Pfizer (United States) and Arko Laboratories, Ltd. (United States).
Segmentation Overview
The study have segmented the market of Global Animal Vaccines market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines and DNA Vaccines), by Application (Companion Animals {Dogs, Cats, Others}, Cattle, Fish, Pigs, Poultry and Sheep) and Region with country level break-up.
On the basis of geography, the market of Animal Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Trend:
Increasing Research and Development in Animal Vaccines
Market Growth Drivers:
Growth in Demand for Pet Insurance, Increase in Prevalence of Animal Diseases, Growth in Ownership of Companion Animal and The Rise in Animal Health Expenditure
Challenges:
Lack of Awareness About Vaccination
Restraints:
Highly Competitive Meat and Milk Prices and Adverse Impact of Veterinary Vaccines on Human and Animal Health
Opportunities:
Advancement in Vaccine Products and Increase in Demand for Hybrid Animals
Market Leaders and their Expansionary Development Strategies
On 12 October 2018, Boehringer Ingelheim inaugurated its new global center for biological research and development at its Lyon Porte-des-Alpes (LPA) location in Saint-Priest France, in the presence of Delphine Gény-Stephann, Secretary of State, attached to the Minister of Economy and Finance. With this 70 million euro investment, the German group signals its intention to reinforce its leading position in the veterinary vaccine market by bringing its R&D and biological production activities into the same center of excellence.
On 26 April 2018, Zoetis, a leading animal vaccines manufacturer announced to expansion of animal vaccine research and manufacturing in Suzhou, China. The company begins construction of state-of-the-art vaccine manufacturing and research and development facilities in Suzhou to support growth. Operations to focus on the development and manufacturing of vaccines for pigs, cattle and fish, and companion animals tailored to the animal health needs of China
Regulatory authorities for vaccination are the Ministry of Health and Family Welfare, the National Technical Advisory Group on Immunization, the Indian Council for Medical Research, and the Central Drugs Standard Control Organization.
Key Target Audience
Animal Vaccine Manufacturers, Animal Vaccine Raw Material Suppliers, Animal Vaccine Traders/Distributors, Animal Vaccine Importer/Exporter, Research & Consulting Firms, Regulatory & Government Bodies and Others
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.